We then conclude that the activation of pro-inflammatory pathways may underlie, at least to a certain extent, the anti-angiogenic and anti-melanoma effect of PDGFR-alpha via CXCL10/IP-10. The gene discussed is PDGFRA; the disease is melanoma.